Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

TARO PHARMACEUTICAL INDUSTRIES LTD.

(TARO)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
07/23/2021 07/26/2021 07/27/2021 07/28/2021 07/29/2021 Date
70.44(c) 70.61(c) 70.74(c) 72.36(c) 70.41(c) Last
17 748 11 200 3 871 19 498 18 552 Volume
+0.30% +0.24% +0.18% +2.29% -2.69% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 617 M - -
Net income 2022 98,5 M - -
Net Debt 2022 - - -
P/E ratio 2022 26,9x
Yield 2022 -
Sales 2023 646 M - -
Net income 2023 167 M - -
Net Debt 2023 - - -
P/E ratio 2023 15,5x
Yield 2023 -
Capitalization 2 658 M 2 658 M -
Capi. / Sales 2022 4,31x
Capi. / Sales 2023 4,12x
Nbr of Employees 1 417
Free-Float 18,7%
More Financials
Company
Taro Pharmaceutical Industries Ltd. (Taro) is a science-based pharmaceutical company. The Company operates principally through three entities: Taro Pharmaceutical Industries Ltd. (Taro Israel), and two of its subsidiaries, Taro Pharmaceuticals Inc. (Taro Canada) and Taro U.S.A. The Company markets over 200 pharmaceutical products in over 25 countries. The Company's owned product brands include Rokacet, with generic... 
Sector
Pharmaceuticals
Calendar
11/09Earnings Release
More about the company
Ratings of Taro Pharmaceutical Industries Ltd.
Trading Rating :  -
Investor Rating : 
ESG Refinitiv : 
C-
More Ratings
All news about TARO PHARMACEUTICAL INDUSTRIES LTD.
07/28TARO PHARMACEUTICAL INDUSTRIES : HC Wainwright Adjusts Taro Pharmaceutical Indus..
MT
07/28TARO PHARMACEUTICAL INDUSTRIES : Fiscal Q1 Adjusted Earnings Per Share, Revenue ..
MT
07/28TARO PHARMACEUTICAL INDUSTRIES : PROVIDES RESULTS FOR QUARTER ENDED JUNE 30, 202..
PU
07/27TARO : Fiscal Q1 Earnings Snapshot
AQ
07/27TARO PHARMACEUTICAL INDUSTRIES : Provides Results for Quarter Ended June 30, 202..
BU
07/26EQS-ADHOC : Cassiopea SpA and Sun Pharma Announce Signing of License and Supply ..
DJ
07/21TARO PHARMACEUTICAL INDUSTRIES : to Announce First Quarter Results on July 27, 2..
AQ
07/20TARO PHARMACEUTICAL INDUSTRIES : to Announce First Quarter Results on July 27, 2..
BU
07/15TARO PHARMACEUTICAL INDUSTRIES : announces RESIGNATION OF CHIEF FINANCIAL OFFICE..
PU
07/15TARO PHARMACEUTICAL INDUSTRIES : CFO to Resign, Process to Identify Successor In..
MT
07/14TARO PHARMACEUTICAL INDUSTRIES : Announces Resignation of Chief Financial Office..
BU
07/14Taro Pharmaceutical Industries Ltd. Announces Resignation of Daphne Huang, Ch..
CI
06/21TARO PHARMACEUTICAL INDUSTRIES : Annual Report on Form 20-F Available For Fiscal..
AQ
06/18TARO PHARMACEUTICAL INDUSTRIES : Annual Report on Form 20-F Available For Fiscal..
BU
06/17TARO PHARMACEUTICAL INDUSTRIES : Annual Report (SEC Filing - 20-F)
PU
More news
News in other languages on TARO PHARMACEUTICAL INDUSTRIES LTD.
07/26EQS-ADHOC : Cassiopea SpA und Sun Pharma kündigen Unterzeichnung von Lizenz- und..
2016USA-L'enquête du DoJ sur les prix des génériques avance -presse
More news
Analyst Recommendations on TARO PHARMACEUTICAL INDUSTRIES LTD.
More recommendations
Chart TARO PHARMACEUTICAL INDUSTRIES LTD.
Duration : Period :
Taro Pharmaceutical Industries Ltd. Technical Analysis Chart | TARO | IL0010827181 | MarketScreener
Technical analysis trends TARO PHARMACEUTICAL INDUSTRIES LTD.
Short TermMid-TermLong Term
TrendsNeutralBearishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Last Close Price 70,41 $
Average target price 82,00 $
Spread / Average Target 16,5%
EPS Revisions
Managers and Directors
Uday Vijaykumar Baldota Chief Executive Officer & Director
Daphne Yan Huang VP, Chief Financial & Accounting Officer
Dilip Shantilal Shanghvi Chairman
Avi Avramoff Vice President & Head-Research & Development
Richard Glaze Vice President & Head-Information Technology
Sector and Competitors
1st jan.Capi. (M$)
TARO PHARMACEUTICAL INDUSTRIES LTD.-4.10%2 732
JOHNSON & JOHNSON9.40%453 418
ROCHE HOLDING AG12.49%332 374
PFIZER, INC.18.04%243 220
ELI LILLY AND COMPANY46.00%224 084
NOVARTIS AG0.39%223 750